Podcast
MSL Talk: Tom Caravela, Alyson Evans
KPIs: Why Quantitative WON’T Work Without Qualitative Outcomes
Summary
In this episode, Linda Traylor and Rena Patel join Tom Caravela to share their insights on the evolving landscape of the MSL profession. They discuss the significance of networking, understanding KPIs, and the integration of qualitative outcomes to measure MSL value. The conversation highlights the adaptation of KPIs due to COVID-19 and the shift towards virtual engagement. The guests emphasize the importance of tactical planning and motivation strategies for MSL teams, along with lifelong learning and the benefits of MSL coaching. The episode concludes with tips for top performance and the necessity of continuous learning and adaptability in the field.
This episode is sponsored by IQVIA. www.iqvia.com
Linda Traylor, Sr Principal and Rina Patel, Director Medical Affairs at IQVIA discuss KPIs and the importance of qualitative Outcomes
Linda and Rina share…
👉 What are KPIs and why are they so important
👉 Does medical affairs have standards for KPIs
👉 Their approach to establishing KPIs and what is most important to track
👉 How medical affairs leaders align quantitative metrics with qualitative ones
👉 What qualitative outcomes should MSLs hope to achieve and why
👉 How the value of MSLs should be measured from a company perspective
MSL profession, networking in medical affairs, KPI integration, virtual engagement strategies, MSL coaching benefits
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Alyson Evans
Podcast
MSL Talk: Tom Caravela, Doug Yau
Emotional Intelligence and the MSL: More Important than EVER
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO